ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER, ANAGENT THAT PREVENTS GAS RETENTION, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF

摘要

The invention relates to a pharmaceutical formulation or composition intendedto beadministered orally in the form of a tablet, a coated tablet or a capsule, forthe prevention ortreatment of intestinal disorders, such as irritable bowel syndrome,comprising an intestinalmotility modifier, an agent that prevents gas retention, digestive enzymes, abinding agent, adiluent, an adsorbent agent, a disintegrating agent, a lubricant and aglidant, effective fornormalising colon transit, for providing an analgesic activity, for providingan antispasmodicactivity and for reducing symptoms related to intestinal gas, such asdistention, abdominal painand flatulence.